ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 53 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $205,000 | +19.2% | 22,300 | 0.0% | 0.00% | – |
| Q4 2016 | $172,000 | -32.5% | 22,300 | 0.0% | 0.00% | – |
| Q3 2016 | $255,000 | +22.6% | 22,300 | +32.0% | 0.00% | – |
| Q2 2016 | $208,000 | -19.1% | 16,900 | +48.2% | 0.00% | – |
| Q4 2015 | $257,000 | +21.2% | 11,400 | -10.9% | 0.00% | – |
| Q3 2015 | $212,000 | -26.4% | 12,800 | 0.0% | 0.00% | – |
| Q2 2015 | $288,000 | +25.8% | 12,800 | +43.8% | 0.00% | – |
| Q1 2015 | $229,000 | +102.7% | 8,900 | +71.2% | 0.00% | – |
| Q4 2014 | $113,000 | -9.6% | 5,200 | -21.2% | 0.00% | – |
| Q3 2014 | $125,000 | -17.2% | 6,600 | +1.5% | 0.00% | – |
| Q2 2014 | $151,000 | +202.0% | 6,500 | +341.3% | 0.00% | – |
| Q1 2014 | $50,000 | +2400.0% | 1,473 | +1917.8% | 0.00% | – |
| Q4 2013 | $2,000 | +100.0% | 73 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |